GAD in Children and Adolescents: Symptoms, Diagnosis, and Treatment
Updated: Oct 8
Author: Ukrainian Psychological Hub · Published: September 30, 2026 · Editorial Policy
Generalized anxiety disorder (GAD) in children and adolescents is a clinical anxiety disorder in which excessive, difficult-to-control worry spreads across multiple areas of life and persists long enough to cause meaningful distress or interfere with school, family life, friendships, sleep, health, or everyday functioning. Young people may worry about grades, mistakes, family safety, health, friendships, future events, punctuality, performance, or whether they have disappointed someone. The National Institute of Mental Health notes that children and adolescents with GAD often worry excessively about school, sports, friendships, the future, making mistakes, and disappointing others.
A child who worries a lot does not automatically have GAD. Worry is part of normal development, especially around transitions, tests, conflict, illness, separation, social evaluation, and uncertainty. GAD is identified from a broader pattern: the worry is excessive for the developmental context, difficult to control, persistent, accompanied by other symptoms, and clinically significant. A questionnaire score can support assessment, but it cannot establish the diagnosis by itself.
This page owns the developmental GAD intent: what GAD looks like in children and adolescents, how clinicians diagnose it, how screening fits into assessment, how it is distinguished from other conditions, and what evidence supports treatment. For the broader disorder across the lifespan, see Generalized Anxiety Disorder: Symptoms, Causes, Diagnosis, and Treatment. For the broader pediatric assessment process, see Anxiety Assessment in Children and Adolescents.
What Is GAD in Children and Adolescents?
GAD is organized around broad, recurring apprehension rather than fear of one narrowly defined object or situation. A young person may move from one worry to another throughout the day: an assignment, a parent's health, a friendship, an upcoming event, an ordinary bodily sensation, a possible mistake, or a future problem that has not happened. The topics change, while the underlying pattern of sustained anticipation and difficulty disengaging from worry remains.
The current major diagnostic systems recognize GAD within the anxiety or fear-related disorders family. WHO's ICD-11 Clinical Descriptions and Diagnostic Requirements provide the international diagnostic framework, while DSM-5-TR is widely used in the United States. Their wording and organization differ in details, so clinicians apply the system relevant to their setting rather than treating DSM-5-TR and ICD-11 as interchangeable checklists.
GAD also remains diagnostically distinct from separation anxiety disorder, social anxiety disorder, specific phobia, panic disorder, agoraphobia, and selective mutism. For the category-level map, see Anxiety Disorders: Symptoms, Types, Diagnosis, and Treatment.
GAD Versus Normal Worry in Young People
Children and adolescents need the capacity to anticipate problems. Worry can motivate preparation, signal that something matters, or prompt a young person to ask for help. The clinical question is therefore not whether worry exists, but how it behaves.
Normal worry is usually proportionate to a recognizable situation, can be redirected, and tends to settle when the situation resolves. In GAD, worry is more pervasive and sticky. It may continue after useful planning is complete, shift immediately to a new topic, or trigger repeated checking, reassurance seeking, overpreparation, avoidance, procrastination, or attempts to eliminate all uncertainty before acting.
Functional impact is central. A young person can appear highly successful while spending enormous effort trying to prevent mistakes or uncertainty. Conversely, the same anxiety can produce school avoidance, incomplete work, irritability at home, sleep disruption, repeated requests for reassurance, or withdrawal from age-appropriate activities. For the general threshold between ordinary anxiety and disorder, see Anxiety: When Normal Worry and Fear Become a Disorder.
Symptoms of GAD in Children and Adolescents
GAD has a cognitive-emotional core—excessive, difficult-to-control worry—and a set of associated emotional, behavioral, and physical symptoms. AACAP describes pediatric GAD as chronic, excessive anxiety about multiple areas such as family, school, social situations, health, and natural disasters. The exact presentation depends on age, temperament, family context, and current demands.
Worry and Mental Symptoms
Common patterns include persistent concern about performance, repeated anticipation of unlikely negative outcomes, difficulty tolerating not knowing what will happen, repeated mental review of decisions, and trouble shifting attention away from possible problems. Some young people ask the same question repeatedly because relief from reassurance fades quickly. Others keep worries private and instead appear unusually careful, perfectionistic, or indecisive.
Concentration problems can occur because attention is repeatedly captured by threat predictions and internal checking. That symptom is not specific to GAD: concentration difficulty also occurs with depression, ADHD, sleep deprivation, trauma-related states, medication effects, substance use, and medical conditions. See Cognitive Symptoms of Anxiety: Worry, Threat Monitoring, Doubt, and Concentration for the broader cognitive symptom map.
Physical and Somatic Symptoms
Children may report headaches, stomachaches, muscle tension, fatigue, restlessness, sweating, shakiness, sleep problems, or a sense of being physically keyed up. MedlinePlus and the Merck Manual Professional Edition both describe somatic complaints as part of pediatric GAD presentations.
Physical symptoms should not be assigned to anxiety simply because anxiety is present. New, severe, persistent, unexplained, or atypical symptoms warrant appropriate medical evaluation. A clinician may review sleep, nutrition, medication and stimulant use, caffeine or other substances, endocrine or cardiopulmonary symptoms, pain, and other medical factors when the history suggests them. GAD is a psychiatric diagnosis made after considering better explanations, not a default label for unexplained bodily symptoms.
Behavioral Signs
Behavior may reveal anxiety before a child can describe it. Repeated reassurance seeking, overchecking homework, refusing to submit work until it feels perfect, excessive preparation, procrastinating because a task feels risky, avoiding unfamiliar activities, insisting on detailed plans, or becoming distressed by last-minute changes can all be part of an anxious pattern. None of these behaviors is diagnostic on its own.
Avoidance often provides short-term relief while preventing the young person from learning that uncertainty, mistakes, or anxious sensations can be tolerated. This learning process is one reason behavioral practice matters in CBT. See Anxiety and Avoidance: How Avoidance Maintains Fear.
How GAD Can Look Different by Age
School-Age Children
Younger children may have difficulty naming worry as an internal process. Anxiety can appear through repeated questions, clinging to routines, reluctance to try new tasks, stomachaches before school, perfectionism, irritability, tearfulness, or a strong need for adult reassurance. Their concerns often center on family safety, school performance, being on time, illness, natural disasters, or whether something bad might happen.
Developmental context matters. A fear that is ordinary at one age can be unusual in intensity, persistence, or functional impact at another. Clinicians therefore evaluate the pattern relative to the child's developmental stage rather than using adult expectations as the reference point.
Adolescents
Adolescents often have a wider range of realistic responsibilities, so the line between ordinary worry and GAD can be less obvious. Concerns may involve grades, future education, appearance, relationships, family finances, health, social status, world events, driving, work, or long-term plans. GAD becomes clinically plausible when the worry is excessive, persistent, difficult to control, and costly to functioning rather than merely reflecting a demanding life.
Teenagers may hide symptoms to avoid appearing vulnerable or may describe anxiety as insomnia, exhaustion, irritability, inability to focus, procrastination, physical discomfort, or feeling constantly under pressure. Assessment works best when the clinician creates space for the adolescent's own account instead of relying exclusively on adult observations.
How GAD Is Diagnosed in Children and Adolescents
GAD is diagnosed through clinical assessment, not a blood test, brain scan, or questionnaire cutoff. The evaluation asks whether the pattern of worry and associated symptoms fits a recognized diagnostic framework, causes clinically significant distress or impairment, and is not better accounted for by another psychiatric disorder, a medical condition, medication, or substance.
The AACAP clinical practice guideline addresses assessment and treatment of anxiety disorders in children and adolescents. A pediatric evaluation commonly integrates the child's or adolescent's report with caregiver information and, when useful, information from school or other settings because anxiety can look different across contexts.
A clinician will usually ask about the onset and duration of symptoms, the subjects of worry, how controllable the worry feels, associated symptoms, sleep, school attendance and performance, family and peer functioning, avoidance, reassurance seeking, medical history, medications and substances, developmental history, previous mental health symptoms, and safety concerns. The assessment is designed to explain the whole pattern, not merely count symptoms.
DSM-5-TR Features in Youth
DSM-5-TR describes GAD as excessive anxiety and worry about multiple events or activities, occurring more days than not for at least six months, with difficulty controlling the worry. In children, only one associated symptom is required, whereas adults require more associated symptoms. The Merck Manual Professional Edition summarizes this pediatric distinction and emphasizes clinically significant distress or impairment.
The associated symptom set includes restlessness or feeling keyed up, easy fatigue, difficulty concentrating, irritability, muscle tension, and sleep disturbance. A child can have several of these symptoms, but the diagnostic core remains the persistent, excessive, difficult-to-control worry pattern. A symptom list without that pattern does not establish GAD.
DSM criteria also require that symptoms are not attributable to a substance or medical condition and are not better explained by another mental disorder. This is why differential diagnosis is part of diagnosis rather than an optional extra.
ICD-11
ICD-11 uses its own clinical descriptions and diagnostic requirements. It also frames GAD around persistent generalized apprehension or worry accompanied by additional anxiety symptoms and meaningful impairment. For a focused explanation, see GAD ICD-11 Diagnostic Requirements Explained. For system-level differences, see DSM-5-TR vs ICD-11 Anxiety Disorders: Key Classification Differences.
Screening Tools Are Not Diagnostic Tests
Screening is designed to identify children or adolescents who may need further evaluation. The U.S. Preventive Services Task Force recommends screening for anxiety in children and adolescents ages 8 to 18 and concludes that evidence is insufficient to assess screening in children 7 years or younger. A positive screen is a reason to look more closely; it is not a diagnosis.
The SCARED was developed as a child- and parent-report instrument for anxiety symptoms and can support screening across several pediatric anxiety domains. The original validation work by Birmaher and colleagues explicitly describes it as a screening instrument. See the Hub's SCARED Anxiety Screen: What It Measures in Children and Adolescents for scoring and interpretation.
The GAD-7 is widely used in adults and has also been studied in adolescents. A validation study in adolescents with GAD found that GAD-7 scores tracked anxiety severity, but that does not transform the scale into a stand-alone diagnostic test. Mossman and colleagues evaluated it as a brief severity measure in adolescents already diagnosed with GAD.
The Pediatric Anxiety Rating Scale (PARS) is clinician-rated and was developed to measure pediatric anxiety severity and impairment across common anxiety disorders, including GAD. Its psychometric study supports use for severity measurement and treatment research rather than replacement of a diagnostic interview.
For the broader distinction, see Anxiety Screening vs Diagnosis: Why a Questionnaire Is Not a Clinical Diagnosis.
Differential Diagnosis: What Can Look Like Pediatric GAD?
Differential diagnosis asks which condition best explains the pattern and whether more than one condition is present. Children and adolescents can have comorbid disorders, so distinguishing diagnoses does not mean assuming only one diagnosis is possible.
Normal Developmental Worry and Stress
Stress before examinations, transitions, conflict, illness, or major changes can produce real anxiety without meeting criteria for GAD. The key questions are proportionality, persistence, controllability, breadth across domains, and impairment. A short period of intense worry during an identifiable stressor is not automatically GAD.
Separation Anxiety Disorder
Separation anxiety disorder is organized around excessive fear or anxiety about separation from attachment figures. A child with GAD may worry about family members, but the worry is broader and extends across multiple domains. The two disorders can also co-occur.
Social Anxiety Disorder
Social anxiety disorder centers on social evaluation, embarrassment, rejection, or performance situations. GAD can include social worries, but the anxiety is not limited to social scrutiny. A teenager whose worry occurs mainly before presentations, parties, conversations, or being watched may need assessment for social anxiety rather than having those symptoms folded into GAD.
Specific Phobia
Specific phobia is organized around a circumscribed feared object or situation, such as an animal, injection, blood, height, or flying. GAD is broader. A child can have both a specific phobia and GAD, but one does not become a subtype of the other.
Panic Disorder
Panic attacks are abrupt episodes of intense fear or discomfort with physical and cognitive symptoms. Panic disorder is organized around recurrent unexpected panic attacks and persistent concern or behavioral change related to future attacks. Panic attacks can occur in GAD, but they are not required for GAD and do not by themselves establish panic disorder.
Obsessive-Compulsive Disorder
OCD is classified separately from anxiety disorders in current major diagnostic systems. Intrusive obsessions and compulsions performed to reduce distress can superficially resemble worry and reassurance seeking. Assessment focuses on the form and function of the thoughts and behaviors rather than labeling every repetitive anxious thought as GAD.
Trauma-Related Disorders
PTSD and other trauma-related disorders are diagnostically separate. Anxiety after trauma may include hyperarousal, avoidance, intrusive memories, nightmares, or trauma-linked beliefs. Those features call for a trauma-focused assessment rather than simply counting anxiety symptoms toward GAD.
Depression
Depression can include concentration problems, sleep disturbance, fatigue, irritability, hopelessness, and repetitive negative thinking. GAD and depression can co-occur. Clinicians therefore assess mood, pleasure, energy, self-worth, suicidality, and the temporal relationship between mood symptoms and worry.
ADHD
Restlessness and concentration difficulty occur in both GAD and ADHD. In GAD, they may intensify when worry is active; in ADHD, attentional and impulse-control difficulties are typically broader and developmentally persistent. The Merck professional review specifically notes the overlap and the possibility of comorbidity.
Autism and Neurodevelopmental Context
Autistic children and adolescents can experience clinically significant anxiety, including GAD, while also having distress related to uncertainty, sensory environments, social demands, change, communication differences, or autistic routines. Assessment should not automatically recast every source of distress as GAD. The clinician asks whether a distinct generalized worry syndrome is present in addition to the young person's neurodevelopmental profile.
Medical Conditions, Sleep, Medications, and Substances
Hyperthyroidism, cardiopulmonary illness, sleep disorders, medication effects, high caffeine intake, stimulants, decongestants, substance use, withdrawal states, and other medical factors can produce symptoms that overlap with anxiety. The appropriate medical differential depends on the history and physical findings; indiscriminate testing is not a substitute for a targeted clinical evaluation.
For a wider map of conditions that can resemble anxiety, see Anxiety Differential Diagnosis: What Can Look Like an Anxiety Disorder?.
Comorbidity
Pediatric GAD often occurs alongside other anxiety disorders, depressive disorders, ADHD, and other conditions. Comorbidity can change how symptoms present, how impairment accumulates, and how treatment is prioritized. For example, a child with GAD and ADHD may need a plan that addresses both worry-driven concentration problems and persistent attentional difficulties. A teenager with GAD and depression may require close assessment of mood, motivation, safety, and functional decline.
Comorbidity also explains why treatment trials that enroll children with several anxiety diagnoses can be clinically useful while still requiring careful interpretation. Evidence from a mixed anxiety sample supports treatment of pediatric anxiety broadly; it does not prove that every disorder responds identically or that every finding is GAD-specific.
What Causes GAD in Children and Adolescents?
There is no single established cause of pediatric GAD. Current models are multifactorial: genetic vulnerability, temperament, learning history, family processes, exposure to stress, cognitive patterns, intolerance of uncertainty, sleep, developmental transitions, and environmental demands can interact over time. A stressful event can intensify symptoms without being the sole cause of the disorder.
Family aggregation is a risk signal, not destiny. Parenting style is also not a simple cause. Caregiver behavior can sometimes become part of a maintenance loop—for example, repeated accommodation can unintentionally help avoidance persist—but blaming parents obscures the reciprocal nature of anxiety and the child's own biology, learning, and context.
Likewise, GAD is not established to result from a single neurotransmitter deficiency. Medication response does not prove a one-chemical cause, just as improvement with CBT does not prove that thoughts alone caused the disorder.
Treatment for GAD in Children and Adolescents
The strongest established treatment families for pediatric anxiety disorders are cognitive behavioral therapy and certain antidepressant medications. The AACAP clinical practice guideline concludes that CBT and SSRIs have considerable empirical support as safe and effective short-term treatments for child and adolescent anxiety disorders, with some support for SNRIs. The guideline also emphasizes remaining gaps in comparative and long-term evidence.
Treatment should match severity, age, developmental level, family circumstances, comorbidity, prior treatment, access, preferences, and the young person's ability to participate. Mild impairment may be approached differently from severe school refusal, pervasive functional decline, or anxiety accompanied by depression or safety concerns.
An important evidence boundary runs through this literature: many high-quality trials combine children with GAD, separation anxiety disorder, and social anxiety disorder. Those studies support pediatric anxiety treatment broadly. GAD-specific claims are strongest when a study enrolled young people with GAD specifically.
Cognitive Behavioral Therapy
CBT is a first-line evidence-based psychotherapy for pediatric anxiety. A large systematic review and meta-analysis by Wang and colleagues found that CBT improved anxiety symptoms, remission, and response compared with waiting-list or no-treatment conditions across childhood anxiety disorders.
Pediatric CBT is structured and developmentally adapted. It commonly includes psychoeducation about anxiety, recognizing worry and bodily arousal, identifying unhelpful predictions, practicing more flexible ways of responding to uncertainty, behavioral experiments, and gradual approach or exposure to situations that have become avoided. Skills are practiced between sessions because learning occurs through repeated experience, not explanation alone.
For GAD, exposure does not need to mean confronting a single phobic object. Behavioral work may involve tolerating uncertainty, making decisions without exhaustive checking, submitting work without perfecting it indefinitely, reducing reassurance loops, approaching age-appropriate activities despite worry, or testing predictions about mistakes and coping. The aim is improved functioning and flexible engagement, not a guarantee that the child will never feel anxious.
Parent involvement is often useful, especially for younger children. Caregivers can learn to validate distress without repeatedly solving every uncertainty, reward approach behavior, support practice, and reduce patterns that make avoidance easier to maintain. The exact level of parent involvement depends on age, family dynamics, and treatment model.
Medication
Medication is considered when anxiety is moderate to severe, causes substantial impairment, has responded incompletely to psychotherapy, or when clinical circumstances make pharmacotherapy appropriate. Medication choice in children and adolescents requires a prescriber who can evaluate medical history, other medications, adverse effects, developmental factors, family preferences, and monitoring needs.
SSRIs have the largest evidence base as a medication class for pediatric anxiety disorders. A systematic review and meta-analysis by Stefánsdóttir and colleagues pooled randomized trials of SSRIs and SNRIs in children and adolescents with anxiety disorders. This is class-level pediatric anxiety evidence, not proof that every medication has the same evidence or regulatory status for GAD.
GAD-specific medication evidence also exists. A small placebo-controlled trial by Rynn and colleagues enrolled 22 children and adolescents ages 5 to 17 with GAD and found greater improvement with sertraline than placebo beginning during the trial. Its small size and age make it supportive rather than definitive on its own.
A larger GAD-specific randomized trial by Strawn and colleagues enrolled 272 youth ages 7 to 17 and found duloxetine superior to placebo on the Pediatric Anxiety Rating Scale after 10 weeks. In the United States, current DailyMed labeling states that duloxetine is indicated for GAD in pediatric patients age 7 years and older and that pediatric efficacy is supported by the 10-week GAD trial.
Regulatory approval is medication- and country-specific. In the United States, many SSRIs used for pediatric anxiety are prescribed off-label for GAD even though the class is supported in pediatric anxiety guidelines. Off-label does not mean unstudied or inappropriate; it means the specific regulatory label does not contain that indication. Families should ask the prescriber what evidence and approval status apply to the proposed medication and age group.
Medication Safety and Monitoring
Antidepressant treatment in young people requires monitoring. DailyMed's duloxetine prescribing information carries the antidepressant boxed warning about increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults and advises close monitoring for clinical worsening or emerging suicidality, especially early in treatment and around dose changes. The same label also calls for regular monitoring of weight and growth in pediatric patients taking duloxetine.
Possible adverse effects vary by medication and can include gastrointestinal symptoms, headache, sleep changes, fatigue, activation or restlessness, appetite or weight changes, and other effects. A prescriber should review the specific medication's label, interactions, contraindications, and discontinuation plan. Families should not start, stop, switch, or rapidly change a psychiatric medication on the basis of an educational article.
If a young person develops new or worsening suicidal thoughts, marked behavioral change, severe agitation, signs of mania, or another concerning reaction after starting or changing medication, the family should contact the treating clinician promptly and seek urgent help when safety is at risk.
A 2026 systematic review and meta-analysis by Karawekpanyawong and colleagues pooled 15 randomized trials involving 2,083 children and adolescents with anxiety disorders. SSRIs and SNRIs reduced anxiety symptoms compared with placebo, while the analysis also found a higher pooled risk of suicidal ideation. This evidence spans pediatric anxiety disorders rather than GAD alone, so it strengthens the case for careful benefit-risk discussion and monitoring without implying the same effect size for every medication, diagnosis, or individual patient.
Combined CBT and Medication
The Child/Adolescent Anxiety Multimodal Study (CAMS), reported by Walkup and colleagues, randomized 488 participants ages 7 to 17 with separation anxiety disorder, GAD, or social phobia to CBT, sertraline, their combination, or placebo. Combination treatment produced the highest acute response in that mixed-anxiety sample.
CAMS is highly influential, but its result should be read correctly: it was not a GAD-only trial. It supports the effectiveness of combined care for pediatric anxiety across the diagnoses studied and provides clinically relevant evidence for young people with GAD, while leaving room for disorder-specific and individual differences.
Combined treatment may be considered when symptoms are more severe, impairment is substantial, one treatment alone has produced only partial improvement, or clinical circumstances favor a multimodal plan. It is not automatically necessary for every child with GAD.
Online CBT and Self-Help
Structured internet-delivered CBT can increase access, particularly when in-person specialists are scarce. A 2026 systematic review and meta-analysis of 11 randomized studies in children and adolescents ages 6 to 18 found a medium pooled benefit for internet-based CBT over control conditions, but the authors rated the overall certainty of evidence as low because of risk of bias and inconsistent reporting. The evidence therefore supports internet CBT as a treatment option while leaving important questions about program quality, therapist support, long-term outcomes, and which young people benefit most.
Self-help can support sleep routines, gradual approach behavior, regular activity, and CBT skills that a clinician has already introduced. It is less appropriate as a stand-alone response when anxiety causes major impairment, school refusal, severe depression, self-harm risk, diagnostic uncertainty, or significant medical symptoms.
What Parents and Caregivers Can Do
Caregivers cannot remove uncertainty from a child's life, and trying to do so can gradually make the child's world smaller. Helpful support combines emotional validation with confidence in the young person's ability to cope. The goal is to make room for anxiety while continuing age-appropriate life.
Listen for the specific fear or prediction before offering reassurance. Understanding the worry is more useful than arguing that the child should not feel it.
Help the child distinguish useful planning from repetitive worry. Once a practical step is complete, repeatedly reopening the same question may strengthen the worry loop.
Support gradual approach to safe, age-appropriate activities rather than allowing anxiety to dictate every decision.
Praise effort, flexibility, and participation rather than only perfect outcomes.
Keep routines around sleep, meals, school attendance, movement, and daily responsibilities as stable as realistically possible.
Coordinate with the child's clinician and school when anxiety affects attendance, assignments, testing, social participation, or health-office visits.
If medication is prescribed, follow the monitoring plan and report meaningful behavioral, mood, sleep, appetite, or safety changes to the prescriber.
School Support
School is often where pediatric GAD becomes visible because it combines performance, deadlines, social evaluation, unpredictability, and separation from home. Support should preserve access to education while avoiding a pattern in which anxiety progressively removes normal demands.
Useful accommodations depend on the individual problem and local educational system. Examples may include a predictable check-in with a designated adult, a plan for making up work after treatment appointments, temporary adjustments during an acute episode, or structured support for returning after school avoidance. Accommodations work best when they support functioning and treatment goals rather than becoming permanent escape routes from every anxiety trigger.
School staff should not be expected to diagnose GAD. Their observations can nevertheless be valuable: attendance patterns, repeated nurse visits, test-related distress, perfectionistic work habits, participation, peer functioning, and differences between classroom and home behavior can all inform clinical assessment.
How Long Does Treatment Take?
There is no single treatment duration for pediatric GAD. Major acute trials commonly evaluate outcomes over roughly 8 to 12 weeks, but clinical care may be shorter or longer depending on severity, comorbidity, response, access, and whether treatment goals involve school reintegration, family accommodation, sleep, or other functional problems.
Improvement also has several dimensions. Worry intensity may decrease before avoidance changes, or a child may return to school while still feeling anxious. Good follow-up therefore measures functioning as well as symptom scores. Relapse prevention typically includes recognizing early warning signs, continuing skills practice, planning for predictable stressors, and knowing when to recontact care.
When to Seek Professional Help
An evaluation is reasonable when worry persists, is difficult to control, repeatedly disrupts sleep or concentration, causes school avoidance or declining performance, limits friendships or activities, produces frequent physical complaints, leads to extensive family accommodation, or causes clear distress. Earlier assessment can also be useful when the family is unsure whether symptoms reflect GAD, another anxiety disorder, depression, ADHD, autism-related distress, trauma, a medical condition, or more than one problem.
A pediatrician or primary care clinician can be a starting point and may assess medical contributors, developmental history, and the need for referral. Child and adolescent psychologists, psychiatrists, and other appropriately trained mental health clinicians can provide diagnostic assessment and evidence-based treatment.
When Symptoms Need Urgent Evaluation
Urgent assessment is appropriate when a child or adolescent has suicidal thoughts with intent or planning, a suicide attempt, self-harm with escalating risk, severe behavioral disorganization, inability to maintain basic safety, or another acute psychiatric crisis. Families should use local emergency or crisis services when immediate safety is at risk.
Physical symptoms also deserve medical judgment. Chest pain, fainting, significant breathing difficulty, seizures, new neurologic symptoms, severe dehydration, or other acute medical signs should not be presumed to be anxiety because the young person has GAD or a history of anxiety.
Prognosis and Recovery
GAD can be persistent, episodic, or fluctuate with developmental and environmental demands. A diagnosis does not determine a child's future. Evidence-based treatment can substantially reduce symptoms and restore functioning, while some young people need longer-term or repeated care.
The most meaningful outcome is not a life without worry. Development requires uncertainty, evaluation, mistakes, transitions, and loss of control. Recovery means that worry becomes more manageable, behavior becomes less governed by avoidance, and the young person can participate more fully in school, relationships, family life, sleep, recreation, and future planning.
Frequently Asked Questions
Can children really have generalized anxiety disorder?
Yes. GAD is diagnosed in children and adolescents when a developmentally inappropriate pattern of excessive, difficult-to-control worry persists, is accompanied by associated symptoms, and causes clinically significant distress or impairment.
What do children with GAD worry about?
Common topics include school performance, mistakes, family safety, health, friendships, punctuality, future events, natural disasters, and disappointing other people. The defining feature is breadth and persistence, not one specific topic.
How long must symptoms last for GAD?
Under DSM-5-TR, the core anxiety and worry pattern occurs more days than not for at least six months. Duration is only one part of diagnosis; impairment, associated symptoms, developmental context, and differential diagnosis also matter.
Does a child need all six associated GAD symptoms?
No. DSM-5-TR requires at least one associated symptom in children, whereas adults require more. The clinician still evaluates the full syndrome and whether another condition better explains the presentation.
Can GAD cause stomachaches and headaches in children?
Yes, somatic complaints can accompany anxiety. However, new, severe, persistent, unexplained, or atypical physical symptoms should be medically evaluated rather than automatically attributed to GAD.
Can SCARED diagnose GAD?
No. SCARED is a screening and symptom questionnaire. It can identify elevated anxiety symptoms and support further assessment, but diagnosis requires clinical evaluation.
Can the GAD-7 diagnose a teenager?
No. The GAD-7 can quantify anxiety symptoms and has been studied in adolescents, but a score is not a formal diagnosis and cannot establish the differential diagnosis.
What treatment has the strongest evidence for pediatric anxiety?
CBT and SSRIs have substantial short-term evidence across pediatric anxiety disorders. For pediatric GAD specifically, duloxetine and a small sertraline trial provide medication-specific evidence, while much CBT evidence comes from studies that include several anxiety diagnoses.
Is duloxetine approved for pediatric GAD in the United States?
Yes. Current U.S. labeling states that duloxetine is indicated for generalized anxiety disorder in pediatric patients age 7 years and older. Medication decisions still require individualized prescribing and monitoring.
Are SSRIs approved for pediatric GAD?
Approval depends on the specific medication and country. In the United States, SSRIs are commonly supported by pediatric anxiety evidence and guidelines but are often prescribed off-label for GAD. The prescriber should explain the evidence and regulatory status of the specific medication.
Is combined CBT and medication always better?
No. CAMS found the highest acute response with combined CBT and sertraline in a mixed sample of children with GAD, separation anxiety disorder, or social phobia. Treatment choice should still reflect severity, prior response, preferences, comorbidity, access, and monitoring needs.
Can GAD occur with ADHD, autism, or depression?
Yes. GAD can coexist with ADHD, autism, depressive disorders, and other anxiety disorders. Assessment should identify which symptoms belong to which condition because overlapping features such as restlessness, concentration problems, sleep disruption, and avoidance are not diagnostically specific.
Related Articles
References